Evolution of measles elimination strategies in the United States

Journal of Infectious Diseases

Volumn 189, Issue SUPPL. 1, 2004, Pages

  Hinman, Alan R ^a   Orenstein, Walter A ^b   Papania, Mark J ^b  

^a Task Force for Child Survival and Development   (United States)

^b CENTERS FOR DIS CONTR AND PREV   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; VIRUS VACCINE;

DISEASE TRANSMISSION; ENDEMIC DISEASE; EPIDEMIC; GENOTYPE; HEALTH PROGRAM; HUMAN; IMMUNITY; IMMUNIZATION; INCIDENCE; LABORATORY; LEARNING; MEASLES; PRIORITY JOURNAL; REVIEW; UNITED STATES; VIRUS DIAGNOSIS; VIRUS STRAIN;

EID: 2442502669     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/377694     Document Type: Review

References (29)

1. Langmuir AD. Medical importance of measles. Am J Dis Child 1962; 103:54-6.
2. National Center for Health Statistics. Vital statistics system. Multiple cause-of-death files, 1912-1998. Bethesda, MD: National Center for Health Statistics, 1999.
3. Sencer DJ, Dull HB, Langmuir AD. Epidemiologic basis for eradication of measles in 1967. Public Health Rep 1967; 82:253-6.
4. Hedrich AW. Monthly estimates of the child population "susceptible" to measles, 1900-1931, Baltimore, Maryland. Am J Hyg 1933; 17:613-36.
5. Hinman AR, Brandling-Bennett AD, Nieburg PI. The opportunity and obligation to eliminate measles from the United States. JAMA 1979; 242:1157-62.
6. Conrad J, Wallace R, Witte JJ. The epidemiologic rationale for the failure to eradicate measles in the United States. Am J Public Health 1971; 61:2304-10.
7. Hinman AR, Bart KJ, Orenstein WA, et al. History of measles control efforts. In: Gruenberg EM, ed. Vaccinating against brain syndromes: the campaign against measles and rubella. New York: Oxford University Press, 1986:36-48.
8. Hinman AR, Kirby CD, Eddins DL, et al. Elimination of indigenous measles from the United States. Rev Infect Dis 1983; 5:538-45.
9. Hinman AR, Eddins DL, Kirby CD, et al. Progress in measles elimination. JAMA 1982; 247:1592-5.
10. Centers for Disease Control. Measles surveillance report 11, 1977-1981. Bethesda, MD: US Public Health Service, 1982.
11. Yorke JA, Nathanson N, Pianigiani G, Martin J. Seasonally and the requirements for perpetuation and eradication of viruses in populations. Am J Epidemiol 1979; 109:103-23.
12. Hethcote H. Measles and rubella in the United States. Am J Epidemiol 1983; 117:2-13.
13. Anderson RM, May RM. Directly transmitted infectious diseases: control by vaccination. Science 1982; 215:1053-60.
14. Orenstein WA, Markowitz LE, Hersh BS, Preblud SR, Hinman AR. The elusiveness of measles elimination: ten years and still counting. In: Proceedings of the 23rd Immunization Conference (San Diego, 5-9 June 1989). Atlanta, GA: Centers for Disease Control and Prevention, 1989:67-73.
15. National Vaccine Advisory Committee. The measles epidemic: the problems, barriers, and recommendations. JAMA 1991; 266:1547-52.
16. Santoli JM, Rodewald LE, Maes EF, Battaglia MP, Coronado VG. Vaccines for Children program, United States, 1997. Pediatrics 1999; 104: e15.
17. Birkhead GS, LeBaron CW, Parsons P, et al. The immunization of children enrolled in the special supplemental food program for women, infants, and children (WIC): the impact of different strategies. JAMA 1995; 274:312-6.
18. LeBaron CW, Chaney M, Baughman AL, et al. Impact of measurement and feedback on vaccination coverage in public clinics, 1988-1994. JAMA 1997; 277:631-5.
19. Dini EF, Linkins RW, Sigafoos J. The impact of computer-generated messages on childhood immunization coverage. Am J Prev Med 2000; 18:132-9.
20. Herrera GA, Smith P, Daniels D, et al. National, state, and urban area vaccination coverage levels among children aged 19-35 months - United States, 1998. MMWR CDC Surveill Summ 2000; 49:1-26.
21. Kolasa M, Klemperer-Johnson S, Papania MJ. Progress toward implementation of a second-dose measles immunization requirement for all schoolchildren in the United States. J Infect Dis 2004; 189(Suppl 1): S98-103.
22. World Health Organization. Nomenclature for describing the genetic characteristics of wild-type measles viruses (update). Part 1. Wkly Epidemiol Rec 2001; 76:242-7.
23. World Health Organization. Nomenclature for describing the genetic characteristics of wild-type measles viruses (update). Part II. Wkly Epidemiol Rec 2001; 76:249-51.
24. Rota JS, Rota PA, Redd SB, Pattamadilok S, Bellini WJ. Genetic analysis of measles viruses isolated in the United States, 1995-1996. J Infect Dis 1998; 177:204-8.
25. Rota PA, Liffick SL, Rota JS, et al. Molecular epidemiology of measles viruses in the United States: 1997-2001. Emerg Infect Dis 2002; 8: 902-8.
26. Papania MJ, Orenstein WA. Defining and assessing measles elimination goals. J Infect Dis 2004; 189(Suppl 1):S23-6.
27. DeSerres G, Gay NJ, Farrington CP. Epidemiology of transmissible diseases after elimination. Am J Epidemiol 2000; 151:1039-48.
28. Harpaz R, Papania MJ, McCauley MM, Redd SB. Has surveillance been adequate to detect endemic measles in the United States? J Infect Dis 2004; 189(Suppl 1):S191-5.
29. de Quadros CA, Izurieta H, Venczel L, Carrasco P. Measles eradication in the Americas: progress to date. J Infect Dis 2004; 189(Suppl 1): S227-35.